Authors: L. Ševčík; Jaroslav Klát; Peter Koliba Authors‘ workplace: Porodnicko-gynekologická klinika, FNsP Ostrava, přednosta MUDr. Peter Koliba, CSc. Published in: Ceska Gynekol 2002; (2): 55-58 Category:
Objective: Analysis of risk and protective factors and hormone replacement therapy in the aethio-logy and pathogenesis of ovarian cancer. The role of hormone replacement therapy in the com-plex treatment in women with ovarian cancer is discussed.Design: Reviewed article.Setting: Department of Obstetrics and Gynaecology, University Hospital Ostrava.Methods: Analysis of epidemiological studies.Conclusion: The role of hormone replacement therapy as a risk factor of ovarian cancer has notbeen confirmed. Hormone replacement therapy as a part of supportive and symptomatic therapyhas been acceptable in a great deal of patients with ovarian cancer.
Key words: hormone replacement therapy, ovarian cancer
Don‘t have an account? Create new account
Enter the email address that you registered with. We will send you instructions on how to set a new password.
